(R)-Rivastigmine

• CAT Number: L032605
• CAS Number: 415973-05-6
• Molecular Formula: C14H22N2O2
• Molecular Weight: 250.34
• Purity: ≥95%
• IUPAC Name: [3-[(1R)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
• InChI: InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m1/s1
• InChIKey: XSVMFMHYUFZWBK-LLVKDONJSA-N
• SMILES: CCN(C)C(=O)OC1=CC=CC(=C1)[C@@H](C)N(C)C

(R)-Rivastigmine（Cat No.:L032605）is the enantiomerically pure form of rivastigmine, a reversible cholinesterase inhibitor used to treat symptoms of Alzheimer’s and Parkinson’s disease-related dementia. With selective inhibition of both acetylcholinesterase and butyrylcholinesterase, (R)-Rivastigmine enhances cholinergic neurotransmission by preventing the breakdown of acetylcholine in the brain. Its (R)-configuration contributes to its pharmacological activity and therapeutic efficacy. The compound crosses the blood-brain barrier and is administered orally or via transdermal patches. (R)-Rivastigmine plays a crucial role in managing cognitive decline and improving daily functioning in patients with neurodegenerative disorders.